Cargando…

Adults with congenital heart disease overestimate their physical activity level

BACKGROUND: Physical activity reduces the risk of acquired cardiovascular disease, which is of great importance in patients with congenital heart disease (CHD). There are diverging data whether physical activity level (PAL) differs between patients with CHD and controls. Furthermore, it is unknown i...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Lena, Johansson, Bengt, Wadell, Karin, Thilén, Ulf, Sandberg, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240621/
https://www.ncbi.nlm.nih.gov/pubmed/30480085
http://dx.doi.org/10.1016/j.ijcha.2018.11.005
_version_ 1783371655819558912
author Larsson, Lena
Johansson, Bengt
Wadell, Karin
Thilén, Ulf
Sandberg, Camilla
author_facet Larsson, Lena
Johansson, Bengt
Wadell, Karin
Thilén, Ulf
Sandberg, Camilla
author_sort Larsson, Lena
collection PubMed
description BACKGROUND: Physical activity reduces the risk of acquired cardiovascular disease, which is of great importance in patients with congenital heart disease (CHD). There are diverging data whether physical activity level (PAL) differs between patients with CHD and controls. Furthermore, it is unknown if PAL can be reliably assessed in patients with CHD using self-reported instruments. METHODS: Seventy-five patients with CHD (mean age 37.5 ± 15.5 years, women n = 29 [38.7%]) and 42 age and sex matched controls completed the International Physical Activity Questionnaire (IPAQ) and carried the activity monitor Actiheart over 4 days. Time spent at ≥3 METS ≥21.4 min/day, i.e. reaching the WHO recommendation for PAL to promote health, was used as the outcome measure. Data on PAL obtained from IPAQ were compared with Actiheart. RESULTS: The proportion of individuals reaching target PAL according to IPAQ was similar in patients with CHD and controls (70.7%vs.76.2%, p = 0.52) as well as between patients with simple and complex lesions. There was an overall difference between IPAQ and Actiheart in detecting recommended PAL (72.6%vs.51.3%, p < 0.001). In a subgroup analysis, this difference was also detected in patients but was borderline for controls. The negative predictive value for IPAQ in detecting insufficient PAL was higher in patients than in controls (73%vs.40%). CONCLUSIONS: The proportion of persons reaching sufficient PAL to promote health was similar in patients and controls. The self-reported instrument overestimated PAL in relation to objective measurements. However, with a high negative predictive value, IPAQ is a potentially useful tool for detecting patients with insufficient PAL.
format Online
Article
Text
id pubmed-6240621
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62406212018-11-26 Adults with congenital heart disease overestimate their physical activity level Larsson, Lena Johansson, Bengt Wadell, Karin Thilén, Ulf Sandberg, Camilla Int J Cardiol Heart Vasc Original Paper BACKGROUND: Physical activity reduces the risk of acquired cardiovascular disease, which is of great importance in patients with congenital heart disease (CHD). There are diverging data whether physical activity level (PAL) differs between patients with CHD and controls. Furthermore, it is unknown if PAL can be reliably assessed in patients with CHD using self-reported instruments. METHODS: Seventy-five patients with CHD (mean age 37.5 ± 15.5 years, women n = 29 [38.7%]) and 42 age and sex matched controls completed the International Physical Activity Questionnaire (IPAQ) and carried the activity monitor Actiheart over 4 days. Time spent at ≥3 METS ≥21.4 min/day, i.e. reaching the WHO recommendation for PAL to promote health, was used as the outcome measure. Data on PAL obtained from IPAQ were compared with Actiheart. RESULTS: The proportion of individuals reaching target PAL according to IPAQ was similar in patients with CHD and controls (70.7%vs.76.2%, p = 0.52) as well as between patients with simple and complex lesions. There was an overall difference between IPAQ and Actiheart in detecting recommended PAL (72.6%vs.51.3%, p < 0.001). In a subgroup analysis, this difference was also detected in patients but was borderline for controls. The negative predictive value for IPAQ in detecting insufficient PAL was higher in patients than in controls (73%vs.40%). CONCLUSIONS: The proportion of persons reaching sufficient PAL to promote health was similar in patients and controls. The self-reported instrument overestimated PAL in relation to objective measurements. However, with a high negative predictive value, IPAQ is a potentially useful tool for detecting patients with insufficient PAL. Elsevier 2018-11-17 /pmc/articles/PMC6240621/ /pubmed/30480085 http://dx.doi.org/10.1016/j.ijcha.2018.11.005 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
Larsson, Lena
Johansson, Bengt
Wadell, Karin
Thilén, Ulf
Sandberg, Camilla
Adults with congenital heart disease overestimate their physical activity level
title Adults with congenital heart disease overestimate their physical activity level
title_full Adults with congenital heart disease overestimate their physical activity level
title_fullStr Adults with congenital heart disease overestimate their physical activity level
title_full_unstemmed Adults with congenital heart disease overestimate their physical activity level
title_short Adults with congenital heart disease overestimate their physical activity level
title_sort adults with congenital heart disease overestimate their physical activity level
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240621/
https://www.ncbi.nlm.nih.gov/pubmed/30480085
http://dx.doi.org/10.1016/j.ijcha.2018.11.005
work_keys_str_mv AT larssonlena adultswithcongenitalheartdiseaseoverestimatetheirphysicalactivitylevel
AT johanssonbengt adultswithcongenitalheartdiseaseoverestimatetheirphysicalactivitylevel
AT wadellkarin adultswithcongenitalheartdiseaseoverestimatetheirphysicalactivitylevel
AT thilenulf adultswithcongenitalheartdiseaseoverestimatetheirphysicalactivitylevel
AT sandbergcamilla adultswithcongenitalheartdiseaseoverestimatetheirphysicalactivitylevel